# Nortriptyline and the Risk of Serious Adverse Events

> **NCT07527481** · — · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 5000 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Nortriptyline Hydrochloride

## Key facts

- **NCT ID:** NCT07527481
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 5000 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07527481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07527481, "Nortriptyline and the Risk of Serious Adverse Events". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07527481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*